Documents | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Documents

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Document Type

  • Publication (142)
  • Testimony (88)
  • Microgram (49)
  • DEA Administrator Remarks (29)
  • Speech (21)
  • In the News (5)
  • Announcements (3)

Publication Type

  • Intelligence (72)
  • DEA Administrator (39)
  • Forensics: Quality Management System Documents (32)
  • Drug Prevention (25)
  • Forensics (10)
  • Announcement (3)
  • Recruitment (1)

Drug Name

  • Narcóticos (opioides) (23)
  • Fentanyl (13)
  • Methamphetamine (10)
  • Drugs of Concern (7)
  • Heroin (7)
  • Cannabis (5)
  • Xylazine (5)
  • Marijuana (4)
  • Cocaine (2)
  • Synthetic Opioids (2)
  • Designer Drugs (1)
  • Hallucinogen (1)
  • Ketamine (1)
  • Spice/K2, Synthetic Marijuana (1)
  • Steroids (1)

Topic

  • Forensics: Quality Management System Documents (30)
  • Forensic Sciences (8)
  • Family (1)
  • Self Help/Personal Growth (1)
Clear All Results
340 Results - Showing 61 to 70
DOCUMENT
|
DEA Administrator Remarks

Justice Department Announces Eight Indictments Against China Based Chemical Manufacturing Companies and Employees

Octubre 03, 2023
“Fentanyl is the deadliest drug threat our nation has ever faced. These eight cases are the result of DEA’s efforts to attack the fentanyl supply chain where it starts — in China. Chinese chemical companies are fueling the fentanyl crisis in the United States by sending fentanyl precursors, fentanyl analogues...
Octubre 03, 2023
DOCUMENT
|
Publication

Standard Operating Procedure for the Analysis of Suspected Natural and Synthetic Opioids

Agosto 02, 2023
This document is an internal Drug Enforcement Administration quality system document. The document is updated periodically and is current as of February 1 , 2023 and is provided for informational purposes only. Any sensitive, privileged or otherwise protected information has been redacted, to include the redaction of some document in...
Agosto 02, 2023
DOCUMENT
|
Publication

Standard Operating Procedure for the Analysis of Suspected Methamphetamine

Agosto 02, 2023
This document is an internal Drug Enforcement Administration quality system document. The effective period of the document is January 25, 2023 to November 5, 2023 and it is provided for informational purposes only. Any sensitive, privileged or otherwise protected information has been redacted, to include the redaction of some document...
Agosto 02, 2023
DOCUMENT
|
Publication

Standard Operating Procedure for the Analysis of Suspected Cocaine

Agosto 02, 2023
This document is an internal Drug Enforcement Administration quality system document. The document is updated periodically and is current as of August 2, 2023 and is provided for informational purposes only. Any sensitive, privileged or otherwise protected information has been redacted, to include the redaction of some document in their...
Agosto 02, 2023
DOCUMENT
|
Publication

Standard Operating Procedure for the Analysis of Cannabis Liquids and Extracts

Agosto 02, 2023
This document is an internal Drug Enforcement Administration quality system document. The document is updated periodically and is current as of August 15, 2022 and is provided for informational purposes only. Any sensitive, privileged or otherwise protected information has been redacted, to include the redaction of some document in their...
Agosto 02, 2023
DOCUMENT
|
Publication

Standard Operating Procedure for the Analysis of Suspected Cannabis Plant Material

Agosto 02, 2023
This document is an internal Drug Enforcement Administration quality system document. The document is updated periodically and is current as of August 1, 2022 and is provided for informational purposes only. Any sensitive, privileged or otherwise protected information has been redacted, to include the redaction of some document in their...
Agosto 02, 2023
DOCUMENT
|
Announcements

DEA and FDA Issue Joint Letter to the Public on Actions to Address Shortages in Prescription Stimulants

Agosto 01, 2023
On August 1, 2023, the Drug Enforcement Administration (DEA) and U.S. Food and Drug Administration (FDA) issued a joint letter updating the public on the ongoing prescription stimulant shortages impacting patients across the United States and actions to resolve these shortages. The DEA and FDA are committed to working together...
Agosto 01, 2023
DOCUMENT
|
DEA Administrator Remarks

Statement of Anne Milgram Administrator at a Hearing Entitled Oversight of the Drug Enforcement Administration

Julio 27, 2023
Chair Biggs, Ranking Member Jackson Lee, and distinguished members of the subcommittee: On behalf of the Department of Justice (Department), and in particular the nearly 10,000 employees working at the Drug Enforcement Administration (DEA), thank you for the opportunity to appear before you today to discuss DEA’s work to save...
Julio 27, 2023
DOCUMENT
|
Testimony

Protecting the U.S. Homeland: Fighting the Flow from the Southwest Border

Julio 13, 2023
Americans today are experiencing the most devastating drug crisis in our nation’s history. This is because one drug—fentanyl—has transformed the criminal landscape. Fentanyl is exceptionally cheap to make, exceptionally easy to disguise, and exceptionally deadly to those who take it. It is the leading cause of death for Americans between...
Julio 13, 2023
DOCUMENT
|
DEA Administrator Remarks

DEA Administrator's Remarks on China-Based Chemical Manufacturing Companies and Arrests

Junio 23, 2023
“Today’s announcement is a considerable step forward in our unrelenting fight against fentanyl, targeting the threat where it starts. These companies and individuals are alleged to have knowingly supplied drug traffickers, in the United States and Mexico, with the ingredients and scientific know-how needed to make fentanyl – a drug...
Junio 23, 2023

Paginación

  • Primera página «
  • Anterior
  • Página 6
  • Current page 7
  • Página 8
  • Página 9
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster